InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,836.00
(
-0.05%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
85.81
(
-0.81%
)
Bitcoin
57,192.29
(
2.41%
)
Post# of 252505
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 115378

Tuesday, 06/14/2011 2:55:36 PM

Tuesday, June 14, 2011 2:55:36 PM

Post# of 252505

I disagree with the implication that Denosumab cannot extend survival and with the assertion that Denosumab is not an “anti-cancer” drug.

The results from the Alpharadin (radium-223 chloride) trial #msg-63944830 show that a bone targeted therapy (not an “anti-cancer” drug) can improve OS in CRPC patients with bone metastases.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up